U.S. Neurosurgical Holdings, Inc. (USNU) financial statements (2021 and earlier)
Company profile
| Business Address |
2400 RESEARCH BLVD ROCKVILLE, MD 20850 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| SIC | 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,519 | 2,684 | 1,962 | 1,068 | 1,053 | 1,414 | |||
| Cash and cash equivalents | 1,519 | 2,684 | 1,962 | 1,068 | 1,053 | 1,414 | |||
| Receivables | 1,560 | 1,235 | 898 | 647 | 285 | 316 | |||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 30 | ||
| Capital leases, lessor balance sheet, net investment in direct financing and sales type leases | ✕ | 828 | |||||||
| Other current assets | 154 | 67 | 71 | 98 | 72 | ||||
| Other undisclosed current assets | 12 | 35 | 115 | ||||||
| Total current assets: | 4,061 | 3,986 | 2,943 | 1,848 | 1,525 | 1,760 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 3,727 | 4,816 | 4,964 | 5,603 | 3,742 | ||||
| Long-term investments and receivables | 323 | 320 | |||||||
| Long-term investments | 323 | 320 | |||||||
| Other noncurrent assets | 2,144 | 202 | 485 | 574 | |||||
| Other undisclosed noncurrent assets | (3,742) | ||||||||
| Total noncurrent assets: | 2,144 | 3,929 | 5,301 | 5,538 | 5,926 | 320 | |||
| TOTAL ASSETS: | 6,205 | 7,915 | 8,244 | 7,386 | 7,451 | 2,080 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 227 | 208 | 86 | 80 | 96 | 154 | |||
| Taxes payable | 64 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 227 | 144 | 86 | 80 | 96 | 154 | |||
| Debt | 1,399 | 972 | 936 | 866 | 821 | 525 | |||
| Due to related parties | 13 | 13 | |||||||
| Deferred revenue and credits | ✕ | ✕ | 370 | 257 | 149 | 48 | |||
| Deferred tax liabilities | ✕ | 245 | 191 | 92 | |||||
| Contract with customer, liability | ✕ | 255 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 64 | ||||||||
| Total current liabilities: | 1,881 | 1,614 | 1,524 | 1,299 | 1,070 | 679 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 988 | 1,666 | 2,733 | 2,945 | 3,838 | ||||
| Capital lease obligations | ✕ | 988 | 1,666 | 2,733 | 3,838 | ||||
| Other undisclosed long-term debt and lease obligation | 2,945 | ||||||||
| Liabilities, other than long-term debt | 314 | 1,192 | 1,082 | 784 | 581 | ||||
| Asset retirement obligations | 517 | 491 | 466 | 431 | |||||
| Deferred tax liabilities, net | ✕ | 314 | 675 | 591 | 303 | 150 | |||
| Other liabilities | 15 | ||||||||
| Other undisclosed noncurrent liabilities | 11 | 11 | 11 | ||||||
| Total noncurrent liabilities: | 1,313 | 2,869 | 3,826 | 3,729 | 4,419 | ||||
| Total liabilities: | 3,194 | 4,483 | 5,350 | 5,028 | 5,489 | 679 | |||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 3,011 | 3,432 | 2,894 | 2,358 | 1,962 | 1,401 | |||
| Common stock | 78 | 78 | 78 | 78 | 78 | 78 | |||
| Additional paid in capital | 3,100 | 3,100 | 3,100 | 3,100 | 3,100 | 3,100 | |||
| Retained earnings (accumulated deficit) | (167) | 254 | (284) | (820) | (1,216) | (1,777) | |||
| Total stockholders' equity: | 3,011 | 3,432 | 2,894 | 2,358 | 1,962 | 1,401 | |||
| TOTAL LIABILITIES AND EQUITY: | 6,205 | 7,915 | 8,244 | 7,386 | 7,451 | 2,080 | |||
Income statement (P&L) ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 3,424 | 3,414 | 3,212 | 2,971 | 2,844 | 40 | ||
| Revenue, net | ✕ | ✕ | 3,414 | 3,212 | 2,971 | 2,607 | 40 | |
| Cost of revenue (Cost of Goods and Services Sold) | (20) | |||||||
| Gross profit: | 3,424 | 3,414 | 3,212 | 2,971 | 2,844 | 20 | ||
| Operating expenses | (3,293) | (2,726) | (2,598) | (2,427) | (1,871) | (994) | ||
| Other undisclosed operating loss | (237) | (20) | ||||||
| Operating income (loss): | 131 | 688 | 614 | 544 | 736 | (994) | ||
| Nonoperating income (Investment Income, Nonoperating) | 112 | 7 | 5 | 11 | ||||
| Interest and debt expense | (113) | (153) | (161) | (181) | (184) | (15) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 130 | 542 | 458 | 363 | 552 | (998) | ||
| Income (loss) from equity method investments | (743) | (101) | 638 | 285 | 14 | (31) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (218) | 237 | ||||||
| Income (loss) from continuing operations before income taxes: | (613) | 441 | 878 | 648 | 803 | (1,029) | ||
| Income tax expense (benefit) | 192 | 97 | (342) | (252) | (242) | 362 | ||
| Net income (loss) available to common stockholders, diluted: | (421) | 538 | 536 | 396 | 561 | (667) | ||
Comprehensive Income ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (421) | 538 | 536 | 396 | 561 | (667) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (421) | 538 | 536 | 396 | 561 | (667) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.